Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology

TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Is it possible to predict the future in first-episode psychosis?

J Suvisaari, O Mantere, J Keinänen, T Mäntylä… - Frontiers in …, 2018 - frontiersin.org
The outcome of first-episode psychosis (FEP) is highly variable, ranging from early
sustained recovery to antipsychotic treatment resistance from the onset of illness. For …

[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia

American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …

A method for tapering antipsychotic treatment that may minimize the risk of relapse

MA Horowitz, S Jauhar, S Natesan… - Schizophrenia …, 2021 - academic.oup.com
The process of stopping antipsychotics may be causally related to relapse, potentially linked
to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity …

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic …

MJH Begemann, IA Thompson, W Veling, SS Gangadin… - Trials, 2020 - Springer
Background Antipsychotic medication is effective for symptomatic treatment in schizophrenia-
spectrum disorders. After symptom remission, continuation of antipsychotic treatment is …

Antipsychotic treatment in the maintenance phase of schizophrenia: an updated systematic review of the guidelines and algorithms

Y Shimomura, Y Kikuchi, T Suzuki, H Uchida… - Schizophrenia …, 2020 - Elsevier
Background We updated our previous systematic review regarding clinical guidelines and
algorithms on antipsychotic treatment in the maintenance phase of schizophrenia (doi …

Open dialogue for psychosis

N Putman, B Martindale - Organising mental health services to …, 2021 - api.taylorfrancis.com
Names: Putman, Nick, editor.| Martindale, Brian, editor. Title: Open dialogue for psychosis:
organising mental health services to prioritise dialogue, relationship and meaning/edited by …

Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis

PD McGorry, C Mei, J Hartmann, AR Yung… - Schizophrenia …, 2021 - Elsevier
Over a quarter of a century ago, the formulation of the “at risk mental state” and operational
criteria to prospectively identify individuals at “clinical” or “ultra-high risk”(UHR) for psychosis …

Self‐reported reasons for discontinuation or continuation of antipsychotic medication in individuals with first‐episode schizophrenia

AE Stürup, C Hjorthøj, HD Jensen… - Early Intervention in …, 2023 - Wiley Online Library
Aim Many individuals with schizophrenia discontinue initially prescribed antipsychotics.
Knowledge on reasons for discontinuation among individuals with first‐episode …

An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder

J Faden, C Ramirez, V Martinez… - Expert Review of …, 2024 - Taylor & Francis
Introduction Long-acting injectable (LAI) antipsychotic medications can help improve
treatment adherence in patients with schizophrenia and bipolar disorder. Despite this, they …